Monday, 30 January 2023
Lewis Capaldi, who recently revealed that he has Tourette syndrome, visited the Neupulse research team at the University of Nottingham, to try out a revolutionary new wearable device that is aimed at reducing tics in those with Tourette syndrome.
This Neupulse device, based on research conducted at the University of Nottingham, is now being developed by a University spin-out company, Neurotherapeutics Ltd, to help the millions of people worldwide who live with Tourette syndrome and tic disorders. The Neupulse device is a wrist-mounted, watch-like, device that delivers mild trains of electrical stimulation directly to the nerves in the wrist and influences the brain networks involved in generating tics.
During his visit, Lewis was eager to try out the Neupulse device for himself to see if it could reduce his tics. Professor Stephen Jackson who has led the research at the University of Nottingham said: “The results were remarkable – Lewis stated that the stimulation made him feel calmer and the device clearly suppressed the head and shoulder tics which can be quite painful for him.
“Though the Neupulse device is still early in development, the preliminary results of our UK-wide double-blind clinical trial have been extremely encouraging. This device has the potential to dramatically improve the lives of those with Tourette syndrome, who often face challenges managing their tics, by providing increased control over their tics on demand.”
Lewis Capaldi wearing the prototype wrist device to control tics
Lewis reported that he was impressed by the effects of the device and is eager to try it out again in the future. Stephen added: “He was also very kind to the research team, taking the time for selfies and photographs with the team. He also very generously invited the whole team to his Friday night concert in Nottingham.”
The Neupulse device has the potential to be a game-changer for individuals with Tourette syndrome, and the world is eager to see the results of the clinical trial that will be published later this year. With its innovative technology and promising early results, the Neupulse device is poised to make a significant impact on the lives of those with Tourette's syndrome.
You can sign up to get the latest updates on the Neupulse development of their device and be the first to know when it is available to purchase on www.neupulse.co.uk.
Story credits
More information is available from Professor Stephen Jackson on Stephen.jackson@nottingham.ac.uk
Notes to editors:
About the University of Nottingham
Ranked 32 in Europe and 16th in the UK by the QS World University Rankings: Europe 2024, the University of Nottingham is a founding member of the Russell Group of research-intensive universities. Studying at the University of Nottingham is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.
Nottingham was crowned Sports University of the Year by The Times and Sunday Times Good University Guide 2024 – the third time it has been given the honour since 2018 – and by the Daily Mail University Guide 2024.
The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.
The university is a major employer and industry partner - locally and globally - and our graduates are the second most targeted by the UK's top employers, according to The Graduate Market in 2022 report by High Fliers Research.
We lead the Universities for Nottingham initiative, in partnership with Nottingham Trent University, a pioneering collaboration between the city’s two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.
More news…